Table 4.
No. Patient, % | Score high | Score low | P value |
---|---|---|---|
Gender | 0.337 | ||
Male | 23 (49%) | 22 (59.4%) | |
Female | 24 (51%) | 15 (40.6%) | |
Age (years) | 0.526 | ||
<65 | 34 (72.3%) | 29 (78.4%) | |
≥65 | 13 (27.7%) | 8 (21.6%) | |
T stage | 0.036 | ||
T1 | 3 (6.4%) | 2 (5.4%) | |
T2 | 9 (19.1%) | 7 (19%) | |
T3 | 32 (68.1%) | 17 (45.9%) | |
T4 | 3 (6.4%) | 11 (29.7%) | |
N stage | 0.008 | ||
N0 | 38 (80.8%) | 20 (54%) | |
N+ | 9 (19.2%) | 17 (46%) | |
M stage | 0.001 | ||
M0 | 45 (95.7) | 25 (67.5%) | |
M1 | 2 (4.3%) | 12 (32.5%) | |
Location | 0.341 | ||
Colon | 18 (38.2%) | 18 (48.6%) | |
Colon/Rectum | 29 (61.8%) | 19 (51.4%) | |
AJCC cancer stage | <0.001 | ||
I | 11 (23.4%) | 6 (16.2%) | |
II | 27 (57.4%) | 8 (21.6%) | |
III | 7 (14.9%) | 11 (29.7%) | |
IV | 2 (4.3%) | 12 (32.4%) |